Advertisement

Neonatology pp 439-456 | Cite as

Oxygen Toxicity in Newborns

  • Rodolfo Bracci
  • Serafina Perrone
  • Maximo Vento
  • Giuseppe Buonocore
Reference work entry

Abstract

The first evidence of a relationship between oxygen toxicity and neonatal diseases emerged in the early 1950s, when retinopathy was observed in premature infants breathing high concentrations of oxygen. Oxygen toxicity is due to the development of reactive oxygen species (ROS), such as the superoxide anion (O2), hydrogen peroxide (H202), lipid peroxide (LOOH), peroxyl radicals RO, electron delocalized phenoxyl radical (C6H50), nitric oxide (NO), and the hydroxyl radical (OH). OH is one of the strongest oxidants in nature and may damage tissues. There is no specific scavenger for this radical, and once released, OH reacts with lipoproteins, cell membranes, lipids, proteins, DNA, amino acids, and other molecules causing structural and functional damage to these structures. The main sources of ROS are NADPH oxidase reactions (principally in phagocytes after activation upon exposure to microbes, microbial products, or inflammatory mediators), mitochondrial metabolism, hypoxia-reoxygenation (hypoxanthine-xanthine oxidase reaction), hyperoxia, and paradoxically hypoxia. Abnormal percentage of ROS generation can have pathological consequences if they are lower as well as they are higher than normal. An excess of ROS, in relation to detoxification capacity, is called oxidative stress, a term which expresses the imbalance between oxidants and antioxidants that is a potential cause of damage. If oxidative stress is mild, cell defenses may increase by a mechanism which generally involves enhanced gene expression of ROS scavenging activities. Severe oxidative stress is generally followed by cell injury and plays a role in many kinds of cell death, i.e., apoptosis, necrosis, autophagy, and mitophagy. Oxidative stress has been suggested as a causative agent in pregnancy-related disorders such as recurrent pregnancy loss, preeclampsia, preterm premature rupture of membranes, intrauterine growth restriction, and fetal death. In the fetal-to-neonatal transition, both blood oxygen content and oxygen availability abruptly increase in the first few minutes after birth, eliciting the generation of a burst of ROS. Oxidative stress following hyperoxia has been recognized to be responsible for lung, retina, and red blood cell injury and possibly generalized tissue damage.

Several methods have been proposed in the attempt to detect the presence and the severity of the oxidative stress. Measurements of protein, lipid, and DNA bases oxidation and intracellular redox status are accurate methods. Prevention of ROS tissue damage involves the avoidance of conditions such as infections, asphyxia, hyperoxia, and retinal light exposure, under which excessive ROS occurs. When supplemental oxygen is needed for care, the most prudent approach would be not to tolerate possible hypoxia and not to accept SpO2 values associated with potential hyperoxia, setting the low alarm never <85% and the high alarm never more than 95%. It is imperative to avoid a flip-flop phenomenon that leads to acute and significant changes and fluctuations in SpO2. Preterm infants should be fed early with human expressed milk, which offers an additional protection against free radicals. Although the usefulness of antioxidant protection during pregnancy and in the neonatal period is still under investigation, the risk of tissue damage due to oxidative stress in perinatal period should not be underestimated.

References

  1. Appleby C, Towner RA (2001) Magnetic resonance imaging of pulmonary damage in the term and premature rat neonate exposed to hyperoxia. Pediatr Res 50:502–507PubMedCrossRefGoogle Scholar
  2. Arneson KO, Roberts LJ 2nd (2007) Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Methods Enzymol 433:127–143PubMedCrossRefGoogle Scholar
  3. Asikainen TM, White CW (2004) Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 6:155–167PubMedCrossRefGoogle Scholar
  4. Asikainen TM, Raivio KO, Saksela M, Kinnula VL (1998) Expression and developmental profile of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 19:942–949PubMedCrossRefGoogle Scholar
  5. Askie LM, Darlow BA, Davis PG, Finer N, Stenson B, Vento M, Whyte R (2017) Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database Syst Rev 4:CD011190Google Scholar
  6. Aycicek A, Erel O, Kocyigit A et al (2006) Breast milk provides better antioxidant power than does formula. Nutrition 22:616–619PubMedCrossRefGoogle Scholar
  7. Bancalari E, Claure N (2012) Control of oxygenation during mechanical ventilation in the premature infant. Clin Perinatol 39:563–572PubMedPubMedCentralCrossRefGoogle Scholar
  8. Berger HM, Mumby S, Gutteridge JMC (1995) Ferrous ions detected in iron-overloaded cord blood plasma from preterm and term babies: implications for oxidative stress. Free Radic Res 22:555–559PubMedCrossRefGoogle Scholar
  9. Bhandari V (2008) Molecular mechanism of hyperoxia induced acute lung injury. Front Biosci 13:6653–6661PubMedCrossRefGoogle Scholar
  10. Bracci R, Buonocore G (2003) Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 83:85–96PubMedPubMedCentralCrossRefGoogle Scholar
  11. Brion LP, Bell EF, Raghuveer TS (2003) Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 3:CD003665Google Scholar
  12. Buonocore G, Groenendal F (2007) Antioxidant strategy. Semin Fetal Neonatal Med 12:287–295PubMedCrossRefGoogle Scholar
  13. Buonocore G, Zani S, Perrone S et al (1998) Intraerythrocyte non protein bound iron and plasma malondialdehyde in the hypoxic newborn. Free Radic Biol Med 25:766–770PubMedCrossRefGoogle Scholar
  14. Buonocore G, Perrone S, Longini M et al (2000) Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 47:221–224PubMedCrossRefGoogle Scholar
  15. Buonocore G, Perrone S, Bracci R (2001) Free radicals and brain damage in the newborn. Biol Neonate 79:180–186PubMedCrossRefGoogle Scholar
  16. Buonocore G, Perrone S, Longini M (2002) Oxidative stress in preterm neonate at birth and on seventh day of life. Pediatr Res 52:46–49PubMedCrossRefGoogle Scholar
  17. Buonocore G, Perrone S, Longini M et al (2003) Non protein bound iron as early predictive marker of neonatal brain damage. Brain 126:1224–1230PubMedCrossRefGoogle Scholar
  18. Carloni S, Perrone S, Buonocore G (2008) Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 44:157–164PubMedCrossRefGoogle Scholar
  19. Chandel NS, Shumacker PT (2000) Cellular oxygen sensing by mitochondria: old question, new insight. J Appl Physiol 88:1880–1889PubMedCrossRefGoogle Scholar
  20. Chang E, Hornick K, Fritz KI et al (2007) Effects of hyperoxia on cortical neuronal nuclear function and programmed cell death mechanism. Neurochem Res 32:1142–1149PubMedCrossRefGoogle Scholar
  21. Chow LC, Wright KW, Sola A et al (2003) Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 111:339–345CrossRefPubMedGoogle Scholar
  22. Ciccoli L, Rossi V, Leoncini S et al (2004) Iron release, superoxide production and binding of autologous IgG to band 3 dimers in newborn and adult erythrocytes exposed to hypoxia and hypoxia-reoxygenation. Biochim Biophys Acta 1672:203–213PubMedCrossRefGoogle Scholar
  23. Collins Y, Chouchani ET, James AM et al (2012) Mitochondrial redox signaling at a glance. J Cell Sci 125:801–806PubMedCrossRefGoogle Scholar
  24. Comporti M, Signorini C, Leoncini S et al (2004) Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radic Biol Med 37:724–732PubMedCrossRefGoogle Scholar
  25. Cummings JJ, Polin RA (2016) Oxygen targeting in extremely low birth weight infants. Pediatrics 138(2):e20161576–e20161576Google Scholar
  26. Denis D, Fayon MJ, Berger P et al (2001) Prolonged moderate hyperoxia induced hyperresponsiveness and airway inflammation in newborn rats. Pediatr Res 50:515–519PubMedCrossRefGoogle Scholar
  27. Drӧse S, Brandt U (2012) Molecular mechanism of superoxide production by the mitochondrial respiratory chain. Adv Exp Med Biol 348:145–169CrossRefGoogle Scholar
  28. Drury JA, Jeffers G, Cooke RW (1998) Urinary 8-hydroxydeoxyguanosine in infants and children. Free Radic Res 28:423–428PubMedCrossRefGoogle Scholar
  29. Eiserich JP, Hristova M, Cross CE et al (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393–339PubMedCrossRefGoogle Scholar
  30. Evans PJ, Evans P, Kovar IZ et al (1992) Bleomycin-detectable iron in the plasma of premature and full-term neonates. FEBS Lett 303:210–212PubMedCrossRefGoogle Scholar
  31. Forman HJ, Fukuto JM, Miller T et al (2008) The chemistry of cell signaling by reactive oxygen species and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys 477:183–195PubMedPubMedCentralCrossRefGoogle Scholar
  32. Frank L (1991) Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 11:463–494. 52PubMedCrossRefGoogle Scholar
  33. Frank L, Sosenko IRS (1987) Prenatal development of lung antioxidant enzymes in four species. J Pediatr 110:106–110PubMedCrossRefGoogle Scholar
  34. Friel JK, Martin SM, Langdon M et al (2002) Milk from mothers of both premature and full-term infants provides better antioxidant protection than does infant formula. Pediatr Res 51:612–618PubMedCrossRefGoogle Scholar
  35. Friel JK, Friesen RW, Harding SV, Roberts LJ (2004) Evidence of oxidative stress in full-term healthy infants. Pediatr Res 56:878–882PubMedCrossRefGoogle Scholar
  36. Gitto E, Karbownik M, Reiter RJ et al (2001) Effects of melatonin treatment in septic newborns. Pediatr Res 50:756–760PubMedCrossRefGoogle Scholar
  37. Gitto E, Reiter RJ, Cordaro SP et al (2004) Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 21:209–216PubMedCrossRefGoogle Scholar
  38. Gordon HH, Nitowsky HM, Cornblath M (1955) Studies of tocopherol deficiency in infants and children. I. Hemolysis of erythrocytes in hydrogen peroxide. Am J Dis Child 90:669–681Google Scholar
  39. Gross RT, Bracci R, Rudolph N et al (1967) Hydrogen peroxide toxicity and detoxification in the erythrocytes of newborn infants. Blood 29:481–493PubMedGoogle Scholar
  40. Halliday H (2008) Surfactant, past, present and future. J Perinatol 28(Suppl 1):S47–S56PubMedCrossRefGoogle Scholar
  41. Halliwell B (2007) Biochemistry of oxidative stress. Biochem Soc Trans 35:1147–1150CrossRefPubMedGoogle Scholar
  42. Halliwell B, Gutteridge JMC (1990) The antioxidants of human extracellular fluids. Arch Biochem Biophys 280:1–8PubMedCrossRefGoogle Scholar
  43. Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231–253PubMedPubMedCentralCrossRefGoogle Scholar
  44. Halliwell B, Gutteridge JMC, Cross CE (1992) Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1:598–620Google Scholar
  45. Hoffman DL, Brookes PS (2009) Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J Biol Chem 284:16236–16245PubMedPubMedCentralCrossRefGoogle Scholar
  46. House JT, Schultetus RR, Gravenstein N (1987) Continuous neonatal evaluation in the delivery room by pulse oximetry. J Clin Monit 3:96–100PubMedCrossRefGoogle Scholar
  47. Indo HP, Yen HC, Nakanishi I, Matsumoto K, Tamura M, Nagano Y, Matsui H, Gusev O, Cornette R, Okuda T, Minamiyama Y, Ichikawa H, Suenaga S, Oki M, Sato T, Ozawa T, Clair DK, Majima HJ (2015) A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr 56:1–7PubMedCrossRefGoogle Scholar
  48. Italian Collaborative Group on Preterm Delivery (1991) Absorption of intramuscular vitamin E in premature babies. Dev Pharmacol Ther 16:13–21Google Scholar
  49. Jankov RP, Negus A, Tanswell AK (2001) Antioxidants as therapy in the newborn: some words of caution. Pediatr Res 50:681–687PubMedCrossRefGoogle Scholar
  50. Kalogeris T, Bao Y, Korthuis RJ (2014) Mitochondrial reactive oxygen species: a double edge sword in ischemia/reperfusion vs preconditioning. Redox Biol 2:702–714PubMedPubMedCentralCrossRefGoogle Scholar
  51. Kaludercic N, Deshwal S, Dilisa F (2014) Reactive oxygen species and compartmentalization. Front Physiol 5:1–15CrossRefGoogle Scholar
  52. Koenig JM, Yoder MC (2004) Neonatal neutrophils: the good, the bad and the ugly. Clin Perinatol 31:39–51PubMedCrossRefGoogle Scholar
  53. Kohlhaas M, Maack C (2013) Calcium release microdomains and mitochondria. Cardiovasc Res 98:259–268PubMedCrossRefGoogle Scholar
  54. Kotecha S, Chan B, Azam N et al (1995) Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child 72:F90–F96CrossRefGoogle Scholar
  55. de La Torre A, Lee YY, Oger C, Sangild PT, Durand T, Lee JC, Galano JM (2014) Synthesis, discovery, and quantitation of dihomo-isofurans: biomarkers for in vivo adrenic acid peroxidation. Angew Chem Int Ed Engl 53:6249–6252CrossRefGoogle Scholar
  56. Lambeth JD, Neish AS (2014) Nox enzymes and new thinking on reactive oxygen: a double-edged sword revised. Annu Rev Pathol 9:119–145PubMedCrossRefGoogle Scholar
  57. Langie Sabine AS, Pawel K, Barbara T et al (2010) The effect of oxidative stress on nucleotide-excision repair in colon tissue of newborn piglets. Mutat Res 695(1–2):75–80PubMedCrossRefGoogle Scholar
  58. Ledo A, Arduini A, Asensi MA et al (2009) Human milk enhances antioxidant defenses against hydroxyl radical aggression in preterm infants. Am J Clin Nutr 89:210–215PubMedCrossRefGoogle Scholar
  59. Li JM, Shah AM (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Integr Comp Phys 287:R1014–R1030CrossRefGoogle Scholar
  60. Lindeman JHN, Lentjes EG, van Zoeren-Grobben D et al (2000) Postnatal changes in plasma ceruloplasmin and transferrin antioxidant activities in preterm babies. Biol Neonate 78:73–76PubMedCrossRefGoogle Scholar
  61. Lismont C, Nordorem M, Van Veldohoven PP, Fransen M (2015) Redox interplay between mitochondria ad peroxisomes. Front Cell Dev Biol 3:1–19CrossRefGoogle Scholar
  62. Longini M, Perrone S, Kenanidis A et al (2005) Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med 38:1537–1541PubMedCrossRefGoogle Scholar
  63. Lubec G, Widness JA, Hayde M et al (1997) Hydroxyl radical generation in oxygen-treated infants. Pediatrics 100:700–704PubMedCrossRefGoogle Scholar
  64. Marseglia L, D'Angelo G, Manti S et al (2014) Oxidative mediated aging during the fetal and perinatal period. Oxidative Med Cell Longev 2014:1–8CrossRefGoogle Scholar
  65. Martín JA, Pereda J, Martínez-López I et al (2007) Oxidative stress as a signal to up-regulate gamma-cystathionase in the fetal to neonatal transition in rats. Cell Mol Biol (Noisy-le-Grand) 53(Suppl):OL1010–OL1017Google Scholar
  66. Marzocchi B, Perrone S, Paffetti P et al (2005) Non protein bound and plasma protein oxidant stress at birth. Pediatr Res 58:1–5CrossRefGoogle Scholar
  67. Menshicova F, Tkachev V, Zencov N (2010) Redox-dependent signaling system Nrf2/ARE in inflammation. Mol Biol 44(343):57Google Scholar
  68. Mikami T, Kita K, Tomita S et al (2000) Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans? Free Radic Res 32:235–244PubMedCrossRefGoogle Scholar
  69. Milne GL, Yin H, Hardy KD, Davies SS, Roberts LJ II (2011) Isoprostane generation and function. Chem Rev 111:5973–5996PubMedPubMedCentralCrossRefGoogle Scholar
  70. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13CrossRefPubMedPubMedCentralGoogle Scholar
  71. Njålsson R, Norgren S (2005) Physiological and pathological aspects of GSH metabolism. Acta Paediatr 94:132–137PubMedCrossRefGoogle Scholar
  72. Patz A, Hoeck I, de la Cruz E (1952) Studies on the effect of high oxygen administration in retrolental fibroplasia. Am J Ophthalmol 35:1248–1253PubMedCrossRefGoogle Scholar
  73. Pereira RD, De Long NE, Wang R et al (2015) Angiogenesis in the placenta: the role of reactive oxygen species signaling. Biomed Res Int 2015:814543PubMedPubMedCentralGoogle Scholar
  74. Perrone S, Tatarrano ML, Negro S, Longini M et al (2010) Early identification of the risk for free radical-related diseases in preterm newborns. Early Hum Dev 86:241–244PubMedCrossRefGoogle Scholar
  75. Perrone S, Tei M, Longini M, Santacroce A, Turrisi G, Proietti F, Felici C, Picardi A, Bazzini F, Vasarri P, Buonocore G (2014) Lipid and protein oxidation in newborn infants after lutein administration. Oxidative Med Cell Longev 2014:781454CrossRefGoogle Scholar
  76. Perrone S, Tei M, Longini M, Buonocore G (2016) The multiple facets of lutein: a call for further investigation in the perinatal period. Oxidative Med Cell Longev 2016:5381540Google Scholar
  77. Pitkanen OM, Luukkainen P, Andersson S (2004) Attenuated lipid peroxidation in preterm infants during subsequent doses of intravenous lipids. Biol Neonate 85:184–187PubMedCrossRefGoogle Scholar
  78. Poets C, Arand J, Hummler H et al (2003) Retinopathy of prematurity: a comparison between two centers aiming for different pulse oximetry saturation levels. Biol Neonate 84:A267Google Scholar
  79. Poggi C, Dani C (2014) Antioxidant strategy and respiratory disease of the preterm newborn: an update. Oxidative Med Cell Longev 2014:1–10CrossRefGoogle Scholar
  80. Richter J, Toelen J, Nagatomo T, Jimenez J, Vanoirbeek J, Deprest J (2016) Transplacental administration of rosiglitazone attenuates hyperoxic lung injury in a preterm rabbit model. Fetal Diagn Ther 39(4):297–305PubMedCrossRefGoogle Scholar
  81. Rogers S, Witz G, Anwar M et al (2000) Antioxidant capacity and oxygen radical diseases in the preterm newborn. Arch Pediatr Adolesc Med 154:544–548PubMedCrossRefGoogle Scholar
  82. Saugstad OD (2005) Oxidative stress in the newborn – a 30-year perspective. Biol Neonate 88:228–236PubMedCrossRefGoogle Scholar
  83. Schulze A, White K, Way RC et al (1995) Effect of the arterial oxygenation level on cardiac output, oxygen extraction, and oxygen consumption in low birth weight infants receiving mechanical ventilation. J Pediatr 126:777–784PubMedCrossRefGoogle Scholar
  84. Sejersted Y, Aasland AL, Bjørås M, Eide L, Saugstad OD (2009) Accumulation of 8-oxoguanine in liver DNA during hyperoxic resuscitation of newborn mice. Pediatr Res 66:533–538PubMedCrossRefGoogle Scholar
  85. Semenza GL, Prabhakar NR (2012) The role of hypoxia-inducible factors in oxygen sensing by the carotid body. Adv Exp Med Biol 758:1–5PubMedPubMedCentralCrossRefGoogle Scholar
  86. Sies H (1991) Role of reactive oxygen species in biological processes. Klin Wochenschr 69:965–968PubMedCrossRefGoogle Scholar
  87. Signorini C, Perrone S, Sgherri C (2008) Plasma esterified F2-Isoprostanes and oxidative stress in newborns: role of non protein bound iron. Pediatr Res 63:287–291PubMedCrossRefGoogle Scholar
  88. Silvers KM, Sluis KB, Darlow BA et al (2001) Limiting light-induced lipid peroxidation and vitamin loss in infant parenteral nutrition by adding multivitamin preparations to Intralipid. Acta Pediatr 90:242–249CrossRefGoogle Scholar
  89. Smith JL (1899) The pathological effects due to increase of oxygen tension in the air breathed. J Physiol 24:19–35PubMedPubMedCentralCrossRefGoogle Scholar
  90. Smith CV, Hansen TN, Martin NE et al (1993) Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 34:360–365PubMedCrossRefGoogle Scholar
  91. Sola A, Golombek SG, Montes Bueno MT et al (2014) Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia? Acta Paediatr 103:1009. ISSN 0803-5253PubMedPubMedCentralCrossRefGoogle Scholar
  92. Solberg R, Andresen JH, Escrig R et al (2007) Resuscitation of hypoxic newborn piglets with oxygen induces a dose dependent increase in markers of oxidative stress. Pediatr Res 62:559–563PubMedCrossRefGoogle Scholar
  93. Solberg R, Longini M, Proietti F, Vezzosi P, Saugstad OD, Buonocore G (2012) Resuscitation with supplementary oxygen induces oxidative injury in the cerebral cortex. Free Radic Biol Med 53:1061–1067PubMedCrossRefGoogle Scholar
  94. Song WL, Lawson JA, Reilly D, Rokach J, Chang CT, Giasson B, GA FG (2008) Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid. J Biol Chem 283:6–16PubMedCrossRefGoogle Scholar
  95. Sun SC (2002) Relation of target SpO2 levels and clinical outcome in ELBW infants on supplemental oxygen. Pediatr Res 51:A350Google Scholar
  96. Tan DX, Chen LD, Poeggeler B et al (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1:57–66Google Scholar
  97. Tataranno ML, Perrone S, Buonocore G (2015) Plasma biomarkers of oxidative stress in neonatal brain injury. Clin Perinatol 42(3):529–539PubMedCrossRefGoogle Scholar
  98. Tiina MA, Kari OR, Mika S, Vuokko LK (1998) Expression and development profile of antioxidant enzymes in human lung and liver. Am J Respir Cell Mol Biol 19:942–949CrossRefGoogle Scholar
  99. Tin W, Gupta S (2007) Optimum oxygen therapy in preterm babies. Arch Dis Child Fetal Neonatal Ed 92:F143–F147PubMedPubMedCentralCrossRefGoogle Scholar
  100. Torday JS, Rehan VK (2016) On the evolution of the pulmonary alveolar lipofibroblast. Exp Cell Res 340(2):215–219PubMedCrossRefGoogle Scholar
  101. Ullrich V, Bachscmid M (2000) Superoxide as a messenger of endothelial function. Biochem Biophys Res Commun 278:1–8PubMedCrossRefGoogle Scholar
  102. Vento M (2014) Oxygen supplementation in the neonatal period: changing the paradigm. Neonatology 105(4):323–331PubMedPubMedCentralCrossRefGoogle Scholar
  103. Vento M, Asensi M, Sastre J et al (2002) Hyperoxemia caused by resuscitation with pure oxygen may alter intracellular redox status by increasing oxidized glutathione in asphyxiated newly born infants. Semin Perinatol 26:406–410PubMedCrossRefGoogle Scholar
  104. Vento M, Aguar M, Escobar J et al (2009a) Antenatal steroids and antioxidant enzyme activity in preterm infants: influence of gender and timing. Antioxid Redox Signal 11:2945–2955PubMedCrossRefGoogle Scholar
  105. Vento M, Moro M, Escrig R et al (2009b) Preterm resuscitation with low oxygen causes less oxidative stress, inflammation, and chronic lung disease. Pediatrics 124:439–449CrossRefGoogle Scholar
  106. Viña J, Vento M, Garcia-Sala F et al (1995) L-cysteine and glutathione metabolism are impaired in premature infants due to a cystathionase deficiency. Am J Clin Nutr 61:1067–1069PubMedCrossRefGoogle Scholar
  107. Wolkoff LI, Narula P (2000) Issue in neonatal and pediatric oxygen therapy. Respir Care Clin N Am 6:675–691PubMedCrossRefGoogle Scholar
  108. Yeung MY (2006) Influence of early postnatal nutritional management on oxidative stress and antioxidant defence in extreme prematurity. Acta Paediatr 95:153–163PubMedCrossRefGoogle Scholar
  109. Yuan G, Peng YJ, Reddy VD et al (2013) Mutual antagonism between hypoxia-inducible factors 1á and 2 á regulates oxygen sensing and cardiorespiratory homeostasis. Proc Natl Acad Sci 110:E1788–E1796PubMedCrossRefGoogle Scholar
  110. Zapata J, Gomez JJ, Araque Campo R, Matiz Rubio A, Sola A (2014) A randomised controlled trial of an automated oxygen delivery algorithm for preterm neonates receiving supplemental oxygen without mechanical ventilation. Acta Paediatr 103:928PubMedPubMedCentralCrossRefGoogle Scholar
  111. Zorov DB, Juhaazova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94:909950CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Rodolfo Bracci
    • 1
  • Serafina Perrone
    • 2
  • Maximo Vento
    • 3
  • Giuseppe Buonocore
    • 1
  1. 1.University of SienaSienaItaly
  2. 2.Department of Molecular and Developmental MedicineUniversity Hospital of SienaSienaItaly
  3. 3.Neonatal Research Unit, Health Research Institute Hospital La FeUniversity and Polytechnic Hospital La FeValenciaSpain

Personalised recommendations